retatrutide period VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide peptide menstrual cycle |

Stevanato: a compelling opportunity Stevanato and other fill & finish companies have been swept into the oral GLP-1 narrative

24.2% at 48 weeks in Phase 2 Tirzepatide : Up to 20.9% body weight reduction (SURMOUNT trials) Advantage : Retatrutide Regulatory Status# Retatrutide : Phase 1-3 clinical trials

Each medication is prepared by licensed 503A compounding pharmacies using pharmaceutical-grade ingredients and sterile preparation protocols

Using genetic insights, targeted peptide therapy, and regular lab tracking, her inflammatory markers dropped from dangerously high levels to normal, and her quality of life dramatically improved

Neurol ., 15 (2), 7786

Rhee SG, Yang KS, Kang SW, Woo HA, Chang TS